ISF (526859)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• P/B of 1.21 against book value ₹1.59 provides a rough asset floor; price is not far from stated book value.
• Piotroski F-Score of 6/9 points to no serious near-term financial distress.
• Profit growth of 137.50% and PEG of 0.18 show recent reported earnings improvement, even if the base is low.
• 52-week range of ₹0.75 to ₹1.92 indicates strong market momentum, though prices alone are not evidence of value.

Concerns

• Latest quarter sales and net profit are both ₹0 crore, so the business appears to have no visible current operating revenue.
• Sales growth of -4.76% and ROE of only 2.97% indicate contracting operations and poor capital productivity.
• P/E of 24.36 is not a meaningful margin of safety when latest earnings are absent; dividend yield is zero.
• Promoter holding and debt/equity are N/A, leaving insufficient transparency for a prudent investor.

AI Analysis

At ₹1.92, ISF is a microcap NBFC with a market capitalization of only ₹18 crore. Graham would look first at the balance sheet, and the book value of ₹1.59 means the shareholder is paying 1.21 times book. That is not a distressed bargain; it merely limits the downside if assets are honestly valued. The real problem is profitability. Return on equity is 2.97% and return on capital employed is 1.93%, which is far below what I would demand from any lending institution. A P/E of 24.36 is not justified when the latest quarter reports sales of ₹0 crore and net profit of ₹0 crore. The 137.50% profit growth and 0.18 PEG ratio look exciting, but they are built on a very low and perhaps one-off base. Meanwhile sales have declined by 4.76%. This is not a franchise with pricing power or a durable competitive moat; it is a tiny company lacking scale, with no dividend and no disclosed promoter holding. The Piotroski F-Score of 6 out of 9 is acceptable, but it is not enough to overcome the absence of visible operating activity. My base case is to treat this as a possible turnaround, not a compounder. I need to see real, recurring income from lending or fees, details of the loan book, and a management that can earn a return on equity well above its cost of capital. Until then, a stock that has jumped from ₹0.75 to ₹1.92 is being driven by hope, and hope is not a valuation.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer